Birzeit Pharmaceuticals Company (PEX:BPC)
Palestine · Delayed Price · Currency is JOD · Price in USD 3.910
+0.060 (1.56%)
At close: Nov 12, 2026
PEX:BPC Ratios and Metrics
Market cap in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 107 | 122 | 120 | 120 | 121 | 78 | |
Market Cap Growth | -0.98% | 2.24% | -0.56% | -0.94% | 56.41% | 6.71% |
Enterprise Value | 105 | 120 | 111 | 109 | 111 | 72 |
Last Close Price | 2.77 | 3.11 | 3.00 | 2.98 | 2.94 | 1.85 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.57 | 14.44 | 32.54 | 27.70 | 21.51 | 9.07 |
PS Ratio | 3.21 | 3.60 | 4.15 | 3.93 | 3.64 | 2.41 |
PB Ratio | 1.24 | 1.50 | 1.61 | 1.61 | 1.65 | 1.18 |
P/TBV Ratio | 1.25 | 1.51 | 1.62 | 1.62 | 1.67 | 1.19 |
P/FCF Ratio | 440.44 | 43905.27 | 31.03 | 19.18 | 105.72 | 40.29 |
P/OCF Ratio | 73.97 | 73.87 | 24.23 | 13.93 | 32.84 | 30.02 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.15 | 3.52 | 3.85 | 3.55 | 3.34 | 2.23 |
EV/EBITDA Ratio | 11.15 | 13.93 | 17.27 | 17.63 | 13.99 | 8.45 |
EV/EBIT Ratio | 12.46 | 15.76 | 20.47 | 21.30 | 16.42 | 9.82 |
EV/FCF Ratio | 431.29 | 43002.35 | 28.78 | 17.32 | 97.07 | 37.24 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | - | - | - | 0.01 | 0.02 |
Debt / EBITDA Ratio | 0.09 | - | - | - | 0.11 | 0.17 |
Debt / FCF Ratio | 3.54 | - | - | - | 0.75 | 0.75 |
Net Debt / Equity Ratio | -0.03 | -0.04 | -0.15 | -0.16 | -0.15 | -0.13 |
Net Debt / EBITDA Ratio | -0.29 | -0.39 | -1.71 | -1.98 | -1.37 | -0.98 |
Net Debt / FCF Ratio | -11.09 | -1216.30 | -2.85 | -1.95 | -9.53 | -4.33 |
Asset Turnover | 0.33 | 0.36 | 0.32 | 0.35 | 0.40 | 0.43 |
Inventory Turnover | 1.97 | 2.48 | 2.20 | 2.22 | 2.53 | 2.36 |
Quick Ratio | 4.21 | 4.43 | 4.48 | 6.58 | 7.15 | 6.51 |
Current Ratio | 5.18 | 5.44 | 5.45 | 8.22 | 9.01 | 8.31 |
Return on Equity (ROE) | 9.55% | 10.82% | 4.94% | 5.90% | 8.08% | 14.10% |
Return on Assets (ROA) | 5.26% | 4.98% | 3.76% | 3.62% | 5.08% | 6.11% |
Return on Invested Capital (ROIC) | 8.97% | 9.76% | 7.39% | 7.17% | 9.94% | 12.40% |
Return on Capital Employed (ROCE) | 8.80% | 8.40% | 6.60% | 6.10% | 8.30% | 9.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.37% | 6.93% | 3.07% | 3.61% | 4.65% | 11.03% |
FCF Yield | 0.23% | 0.00% | 3.22% | 5.21% | 0.95% | 2.48% |
Dividend Yield | 1.28% | 1.12% | 1.15% | 1.14% | 2.06% | 1.77% |
Payout Ratio | 17.47% | 16.22% | 37.40% | 63.39% | 24.39% | 23.60% |
Buyback Yield / Dilution | 1.99% | - | - | -2.30% | 2.38% | - |
Total Shareholder Return | 3.27% | 1.12% | 1.15% | -1.15% | 4.44% | 1.77% |